Reaction of rat subcutaneous connective tissue to a mineral trioxide aggregate-based and a zinc oxide and eugenol sealer.
BACKGROUND
The purpose of this study was to evaluate the subcutaneous connective tissue reaction in rats to a mineral trioxide aggregate (MTA)-based endodontic sealer Fillapex (Angelus, Londrina, PR, Brazil) and compare it with Grossman sealer (Farmadental, Buenos Aires, Argentina).


METHODS
Sterile medical-grade silicone tubes containing the test materials were implanted in 24 Wistar rats. After 10, 30, and 90 days, the animals (n = 8 per period) were euthanized, and the implants along with their surrounding tissues were dissected, fixed, and processed for histologic evaluation. A 4-category evaluation system was used to evaluate the microscopic observations. The tissue response on the lateral walls of the silicone tubes was used as the negative control. The data were analyzed for statistical significance using the Wilcoxon signed rank, Kruskal-Wallis, and Dunn tests.


RESULTS
Fillapex showed a severe tissue reaction for all 3 observation periods. Grossman sealer showed similar features after 10 and 30 days, but the reaction decreased slightly after 90 days. In contrast, the negative controls did not show adverse reactions in any sample of the 3 time periods. After 10 and 30 days, no statistically significant differences were found between Fillapex and Grossman sealer (P > .05); however, the difference was significant after 90 days (P < .05). For all experimental periods, there were statistically significant differences between both Fillapex and Grossman sealer and the negative controls (P < .05).


CONCLUSIONS
It was concluded that both MTA-Fillapex and Grossman sealer remained toxic to subcutaneous tissues in rats after 90 days.
Postgraduate Program for Specialized Endodontics, Faculty of Medical Sciences, School of Dentistry, University of El Salvador, Buenos Aires, Argentina.
Osvaldo
O
Zmener
Ricardo
R
Martinez Lalis
Cornelis H
CH
Pameijer
Carolina
C
Chaves
Gabriel
G
Kokubu
Daniel
D
Grana
D017607:Aluminum Compounds / Q000633:toxicity*; D000818:Animals; D001672:Biocompatible Materials / Q000633:toxicity; D017610:Calcium Compounds / Q000633:toxicity*; D002196:Capillaries / Q000473:pathology; D004338:Drug Combinations; D005347:Fibroblasts / Q000473:pathology; D005549:Foreign-Body Reaction / Q000139:chemically induced; D015743:Giant Cells, Foreign-Body / Q000473:pathology; D015745:Granuloma, Foreign-Body / Q000139:chemically induced; D008214:Lymphocytes / Q000473:pathology; D008264:Macrophages / Q000473:pathology; D008297:Male; D008422:Materials Testing; D009504:Neutrophils / Q000473:pathology; D010087:Oxides / Q000633:toxicity*; D010950:Plasma Cells / Q000473:pathology; D051381:Rats; D017208:Rats, Wistar; D012387:Root Canal Filling Materials / Q000633:toxicity*; D017640:Silicates / Q000633:toxicity*; D040521:Subcutaneous Tissue / Q000187:drug effects* / Q000473:pathology; D013997:Time Factors; D015035:Zinc Oxide-Eugenol Cement / Q000633:toxicity*
D017607:Aluminum Compounds; D001672:Biocompatible Materials; D017610:Calcium Compounds; D004338:Drug Combinations; D010087:Oxides; D012387:Root Canal Filling Materials; D017640:Silicates; D015035:Zinc Oxide-Eugenol Cement; C086631:mineral trioxide aggregate; C045432:Grossman's sealer